BBC: Multiple sclerosis: New drug 'most effective'...
University of Cambridge news: New MS drug proves effective where others have failed.... Nature News Blog: MS treatment shows success in clinical trials...... Lancet editorial: Alemtuzumab for multiple sclerosis...... Independent article: New MS wonder drug may be too costly to use..... Reuters: Sanofi draws fire over cost of MS drug Lemtrada.....
Sanofi-Genzyme press release:
CoI: I am a co-author on the CARE-MS1 study, the principal investigator on the CARE-MS1 & 2 studies at Barts Health and have received consultancy and honorarium payments from Genzyme and Sanofi, in relation to alemtuzumab.